NR 565 WEEK 5 QUESTIONS & ANSWERS 2026-2027 | ADVANCED PHARMACOLOGY S… EXAM
P R O F E S S I O N A L P R A C T I C E M AT E R I A L S
NR 565 Week 5 Questions &
Answers 2026-2027 |
Advanced Pharmacology
Study Guide | Exam Review
(Rationales)
Verified Answers Exam Ready With Rationales
51 QUESTIONS
DOCUMENT OVERVIEW
This document contains 51 verified questions with correct answers and detailed rationales focused on
advanced pharmacology. It serves as a comprehensive study guide for understanding key pharmacological
concepts and mechanisms. Ideal for exam review and certification preparation, it enables students to
strengthen their knowledge and grasp critical information effectively.
CONTENTS
01 Thyroid Disorders Q1–Q7
02 Patient Education Q8–Q12
03 Diabetes Management Q13–Q24
04 Respiratory Pharmacology Q25–Q32
Page 1
, 05 Gastrointestinal Pharmacology Q33–Q43
06 Vaccination Guidelines Q44–Q51
E XA M Q U EST I O N S
Q1 QUESTION 1 OF 51
Signs and symptoms of hypothyroidism and hyperthyroidism
CORRECT ANSWER
Hypothyroidism:
Thick, coarse, dry Hyporeflexia, "hung up" patella reflex Slow thought process, Weight gain (5-10 lbs./2.25-4.5 kg)
Constipation, Menorrhagia, Cold intolerance: Cold all the time
Hyperthyroidism (aka graves disease):
Smooth, silky Hyperreflexia, Mind racing, Weight loss (10 lbs./4.5 kg) Diarrhea, loose, frequent stools, Oligomenorrhea,
Heat intolerance: Hot all the time
pg. 418-419
RATIONALE
Thyroid hormones regulate metabolism and influence energy levels, with hypothyroidism causing a decrease in metabolic rate
leading to symptoms like weight gain and cold intolerance, while hyperthyroidism increases metabolism, resulting in weight
loss and heat intolerance. Recognizing these distinct clinical manifestations is critical for accurate diagnosis and
management of thyroid disorders.
Q2 QUESTION 2 OF 51
What adjunctive therapy is good to prescribe to control symptoms of hyperthyroidism other than thyroid specific
medications?
Know drug classes and examples of those drug classes.
CORRECT ANSWER
β-Blockers and nonradioactive iodine may be used as adjunctive therapy. β-Blockers suppress tachycardia by blocking
β-receptors on the heart. Nonradioactive iodine inhibits synthesis and release of thyroid hormones.
pg. 419
RATIONALE
β-Blockers alleviate symptoms of hyperthyroidism, particularly tachycardia, by antagonizing β-adrenergic receptors, thus
reducing heart rate and myocardial contractility. Nonradioactive iodine serves to inhibit the synthesis and release of thyroid
hormones, providing symptomatic relief while awaiting more definitive treatment.
Page 2
, Q3 QUESTION 3 OF 51
Monitoring needs and intervals for thyroid medications.
CORRECT ANSWER
levothyroxine-Monitoring: Check TSH 6-8 weeks after initiating therapy and after any dosage change. Check TSH at
least once a year after serum TSH is stabilized.
Methimazole-Monitoring: Check CBC with differential if signs or symptoms of infection. Check LFTs if signs or
symptoms of liver dysfunction.
Propylthiouracil (PTU)- Treatment continues for 1-2 years
PTU has caused rare cases of liver injury. Onset is sudden and progression is rapid.
RATIONALE
Thyroid medications require specific monitoring protocols to ensure therapeutic efficacy and safety; levothyroxine
necessitates TSH monitoring to adjust dosage effectively, while methimazole and PTU require vigilance for potential
hematologic and hepatic adverse effects. Regular assessments align with clinical guidelines that promote optimal
management of thyroid disorders and mitigate risks associated with medication therapy.
Q4 QUESTION 4 OF 51
- Propylthiouracil (PTU) carries a risk for liver toxicity. Although rare, the FDA recommends against using PTU as a
first-line treatment due to potential for hepatic toxicity.
CORRECT ANSWER
Treatment continues for 1-2 years
PTU has caused rare cases of liver injury. Onset is sudden and progression is rapid. pg 421
RATIONALE
Long-term treatment with propylthiouracil (PTU) is necessary for managing hyperthyroidism, as it inhibits thyroid hormone
synthesis; however, the risk of sudden and severe hepatic injury necessitates careful monitoring and consideration of
alternative therapies, particularly in initial treatment. This highlights the importance of balancing therapeutic efficacy with the
potential for serious adverse effects in pharmacotherapy.
Q5 QUESTION 5 OF 51
Page 3
P R O F E S S I O N A L P R A C T I C E M AT E R I A L S
NR 565 Week 5 Questions &
Answers 2026-2027 |
Advanced Pharmacology
Study Guide | Exam Review
(Rationales)
Verified Answers Exam Ready With Rationales
51 QUESTIONS
DOCUMENT OVERVIEW
This document contains 51 verified questions with correct answers and detailed rationales focused on
advanced pharmacology. It serves as a comprehensive study guide for understanding key pharmacological
concepts and mechanisms. Ideal for exam review and certification preparation, it enables students to
strengthen their knowledge and grasp critical information effectively.
CONTENTS
01 Thyroid Disorders Q1–Q7
02 Patient Education Q8–Q12
03 Diabetes Management Q13–Q24
04 Respiratory Pharmacology Q25–Q32
Page 1
, 05 Gastrointestinal Pharmacology Q33–Q43
06 Vaccination Guidelines Q44–Q51
E XA M Q U EST I O N S
Q1 QUESTION 1 OF 51
Signs and symptoms of hypothyroidism and hyperthyroidism
CORRECT ANSWER
Hypothyroidism:
Thick, coarse, dry Hyporeflexia, "hung up" patella reflex Slow thought process, Weight gain (5-10 lbs./2.25-4.5 kg)
Constipation, Menorrhagia, Cold intolerance: Cold all the time
Hyperthyroidism (aka graves disease):
Smooth, silky Hyperreflexia, Mind racing, Weight loss (10 lbs./4.5 kg) Diarrhea, loose, frequent stools, Oligomenorrhea,
Heat intolerance: Hot all the time
pg. 418-419
RATIONALE
Thyroid hormones regulate metabolism and influence energy levels, with hypothyroidism causing a decrease in metabolic rate
leading to symptoms like weight gain and cold intolerance, while hyperthyroidism increases metabolism, resulting in weight
loss and heat intolerance. Recognizing these distinct clinical manifestations is critical for accurate diagnosis and
management of thyroid disorders.
Q2 QUESTION 2 OF 51
What adjunctive therapy is good to prescribe to control symptoms of hyperthyroidism other than thyroid specific
medications?
Know drug classes and examples of those drug classes.
CORRECT ANSWER
β-Blockers and nonradioactive iodine may be used as adjunctive therapy. β-Blockers suppress tachycardia by blocking
β-receptors on the heart. Nonradioactive iodine inhibits synthesis and release of thyroid hormones.
pg. 419
RATIONALE
β-Blockers alleviate symptoms of hyperthyroidism, particularly tachycardia, by antagonizing β-adrenergic receptors, thus
reducing heart rate and myocardial contractility. Nonradioactive iodine serves to inhibit the synthesis and release of thyroid
hormones, providing symptomatic relief while awaiting more definitive treatment.
Page 2
, Q3 QUESTION 3 OF 51
Monitoring needs and intervals for thyroid medications.
CORRECT ANSWER
levothyroxine-Monitoring: Check TSH 6-8 weeks after initiating therapy and after any dosage change. Check TSH at
least once a year after serum TSH is stabilized.
Methimazole-Monitoring: Check CBC with differential if signs or symptoms of infection. Check LFTs if signs or
symptoms of liver dysfunction.
Propylthiouracil (PTU)- Treatment continues for 1-2 years
PTU has caused rare cases of liver injury. Onset is sudden and progression is rapid.
RATIONALE
Thyroid medications require specific monitoring protocols to ensure therapeutic efficacy and safety; levothyroxine
necessitates TSH monitoring to adjust dosage effectively, while methimazole and PTU require vigilance for potential
hematologic and hepatic adverse effects. Regular assessments align with clinical guidelines that promote optimal
management of thyroid disorders and mitigate risks associated with medication therapy.
Q4 QUESTION 4 OF 51
- Propylthiouracil (PTU) carries a risk for liver toxicity. Although rare, the FDA recommends against using PTU as a
first-line treatment due to potential for hepatic toxicity.
CORRECT ANSWER
Treatment continues for 1-2 years
PTU has caused rare cases of liver injury. Onset is sudden and progression is rapid. pg 421
RATIONALE
Long-term treatment with propylthiouracil (PTU) is necessary for managing hyperthyroidism, as it inhibits thyroid hormone
synthesis; however, the risk of sudden and severe hepatic injury necessitates careful monitoring and consideration of
alternative therapies, particularly in initial treatment. This highlights the importance of balancing therapeutic efficacy with the
potential for serious adverse effects in pharmacotherapy.
Q5 QUESTION 5 OF 51
Page 3
